ARQT logo

Arcutis Biotherapeutics, Inc. (ARQT) Operating Profit

Annual Operating Profit:

-$128.40M+$112.70M(+46.75%)
December 31, 2024

Summary

  • As of today, ARQT annual operating income is -$128.40 million, with the most recent change of +$112.70 million (+46.75%) on December 31, 2024.
  • During the last 3 years, ARQT annual operating profit has risen by +$78.13 million (+37.83%).
  • ARQT annual operating profit is now -3027.06% below its all-time high of -$4.11 million, reached on December 31, 2017.

Performance

ARQT Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

Quarterly Operating Profit:

-$14.61M+$9.92M(+40.43%)
June 30, 2025

Summary

  • As of today, ARQT quarterly operating income is -$14.61 million, with the most recent change of +$9.92 million (+40.43%) on June 30, 2025.
  • Over the past year, ARQT quarterly operating profit has increased by +$35.47 million (+70.82%).
  • ARQT quarterly operating profit is now -145.44% below its all-time high of -$5.95 million, reached on December 31, 2018.

Performance

ARQT Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

TTM Operating Profit:

-$85.84M+$35.47M(+29.24%)
June 30, 2025

Summary

  • As of today, ARQT TTM operating income is -$85.84 million, with the most recent change of +$35.47 million (+29.24%) on June 30, 2025.
  • Over the past year, ARQT TTM operating profit has increased by +$93.93 million (+52.25%).
  • ARQT TTM operating profit is now -1015.50% below its all-time high of -$7.70 million, reached on September 1, 2018.

Performance

ARQT TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

ARQT Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+46.8%+70.8%+52.3%
3Y3 Years+37.8%+77.8%+66.6%
5Y5 Years-197.7%+59.0%+25.7%

ARQT Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+57.4%-91.4%+86.0%at high+72.8%
5Y5-Year-197.7%+57.4%-91.4%+86.0%at high+72.8%
All-TimeAll-Time-3027.1%+57.4%-145.4%+86.0%-1015.5%+72.8%

ARQT Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$14.61M(+40.4%)
-$85.84M(+29.2%)
Mar 2025
-
-$24.53M(-221.4%)
-$121.30M(+5.5%)
Dec 2024
-$128.40M(+46.7%)
-$7.63M(+80.5%)
-$128.40M(+29.4%)
Sep 2024
-
-$39.07M(+22.0%)
-$181.93M(-1.2%)
Jun 2024
-
-$50.08M(-58.4%)
-$179.77M(+8.5%)
Mar 2024
-
-$31.62M(+48.3%)
-$196.46M(+18.5%)
Dec 2023
-$241.10M(+20.1%)
-$61.17M(-65.8%)
-$241.10M(+2.9%)
Sep 2023
-
-$36.90M(+44.7%)
-$248.36M(+21.5%)
Jun 2023
-
-$66.76M(+12.5%)
-$316.20M(-0.3%)
Mar 2023
-
-$76.27M(-11.5%)
-$315.26M(-4.5%)
Dec 2022
-$301.63M(-46.0%)
-$68.42M(+34.7%)
-$301.63M(+0.9%)
Sep 2022
-
-$104.75M(-59.1%)
-$304.49M(-18.6%)
Jun 2022
-
-$65.83M(-5.1%)
-$256.82M(-10.2%)
Mar 2022
-
-$62.63M(+12.1%)
-$233.07M(-12.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$206.53M(-51.1%)
-$71.29M(-24.9%)
-$206.53M(-22.0%)
Sep 2021
-
-$57.08M(-35.6%)
-$169.31M(-12.5%)
Jun 2021
-
-$42.08M(-16.6%)
-$150.53M(-4.5%)
Mar 2021
-
-$36.09M(-5.9%)
-$144.08M(-5.4%)
Dec 2020
-$136.65M(-216.8%)
-$34.06M(+11.1%)
-$136.65M(-18.2%)
Sep 2020
-
-$38.30M(-7.5%)
-$115.58M(-25.7%)
Jun 2020
-
-$35.63M(-24.3%)
-$91.92M(-41.8%)
Mar 2020
-
-$28.65M(-120.5%)
-$64.83M(-50.3%)
Dec 2019
-$43.13M(-118.6%)
-$12.99M(+11.3%)
-$43.13M(-19.5%)
Sep 2019
-
-$14.65M(-71.6%)
-$36.09M(-23.9%)
Jun 2019
-
-$8.54M(-22.8%)
-$29.14M(-41.4%)
Mar 2019
-
-$6.95M(-16.8%)
-$20.60M(-50.9%)
Dec 2018
-$19.73M(-380.6%)
-$5.95M(+22.6%)
-$13.65M(-77.4%)
Sep 2018
-
-$7.70M
-$7.70M
Dec 2017
-$4.11M
-
-

FAQ

  • What is Arcutis Biotherapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. annual operating profit year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. TTM operating profit year-on-year change?

What is Arcutis Biotherapeutics, Inc. annual operating income?

The current annual operating profit of ARQT is -$128.40M

What is the all-time high annual operating profit for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high annual operating income is -$4.11M

What is Arcutis Biotherapeutics, Inc. annual operating profit year-on-year change?

Over the past year, ARQT annual operating income has changed by +$112.70M (+46.75%)

What is Arcutis Biotherapeutics, Inc. quarterly operating income?

The current quarterly operating profit of ARQT is -$14.61M

What is the all-time high quarterly operating profit for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high quarterly operating income is -$5.95M

What is Arcutis Biotherapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, ARQT quarterly operating income has changed by +$35.47M (+70.82%)

What is Arcutis Biotherapeutics, Inc. TTM operating income?

The current TTM operating profit of ARQT is -$85.84M

What is the all-time high TTM operating profit for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high TTM operating income is -$7.70M

What is Arcutis Biotherapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, ARQT TTM operating income has changed by +$93.93M (+52.25%)
On this page